Dr. Rubina Bhutani
Qualification: B.Pharmacy, M.Pharmacy (Pharmaceutical Chemistry), PhD(Pharmaceutical Sciences)
College/University: Guru Jambheshwar University , Hisar (Haryana), Jamia Hamdard, New Delhi, Delhi Institute of Pharmaceutical Sciences & Research (Delhi University).
Introduction: Rubina Wadhwa is an expert in the area of pharmaceutical chemistry and pharmaceutical sciences. She has 3.5 years of teaching experience and 5 Years of research experience during PhD.She is GPAT qualified and got UGC fellowship during post-graduation.
Prior to taking up the current role in 2019, she has completed her Ph.D at Delhi Institute of Pharmaceutical Sciences and Research (DIPSAR), Delhi University, New Delhi. She has been awarded with DST INPIRE Fellowship for her research work in PhD.
Publications (from 2015)
‘Novel Hybrids of Benzothiazole-oxadiazole-4-thiazolidinone: Synthesis, in silico ADME study, molecular docking and in vivo anti-diabetic assessment’, Bioorganic Chemistry, 83, pp. 6-19.(Bhutani, R., Pathak D.P., Kapoor G., Husain A., Iqbal M.A., 2019).
‘Synthesis, molecular modelling studies and ADME prediction of benzothiazole clubbed oxadiazole-Mannich bases, and evaluation of their anti-diabetic activity through in vivo model’, Bioorganic Chemistry, 77, pp. 6-15. (Bhutani, R., Pathak D.P., Kapoor G., Husain A., Kant R., Iqbal M.A., 2018),
‘A Review on recent development of pyrazoline as a pharmacologically active molecule’, International Journal of Pharmaceutical Sciences & Research’, 6(10), pp. 4113-4128. (Bhutani, R., Pathak D.P., Kapoor G., Husain A., Kant R., 2015),
‘Synthesis, ADME, docking studies and in vivo anti-hyperglycaemic potential estimation of novel schiff base derivatives from octadec-9-enoic acid. Bioorganic Chemistry’, 84, pp. 478-492. (Kapoor G., Pathak D.P., Bhutani, R., Husain A., Jain, S., Iqbal M.A., 2019)
‘Novel oxadiazole based mannich base derivatives of fatty acid: Synthesis, in silico study and evaluation of their antihyperglycaemic potential through in vivo model’, Oriental Journal of Chemistry, 34, pp. 2253-2267 (Kapoor G., Pathak D.P., Bhutani, R., Husain A., Jain, S., Kant Ravi., Iqbal M.A., 2018).
‘Enantioselective Box-Behenken optimized RP-HPLC method for simultaneous estimation of alogliptinenantiomorphs in pharmaceutical formulations and their pharmacokinetic study in rat plasma’,Advanced Pharmaceutical Bulletin,9 (1),pp. 147-158.(Kant, R.,Bodla, R., Bhutani, R., Kapoor G., 2019).
‘Recent Developments on Pharmacological potential of 1,3,4-oxadiazole Scaffold’, Indian Journal of Pharmaceutical Education & Research, 53 (2), s1-s16. (Bhutani, R., Pathak D.P., Kapoor G., Husain A., Kant R., Dutta M., 2019)
Advances in synthesis, derivatization and bioactivity of isatin: A review’, Current Organic Synthesis, 18 (1), 37-74. (Chauhan, G., Pathak D.P., Ali, F., Bhutani, R., Kapoor G., Shaik, K., 2021)
‘Current Advancement in the Oxadiazole-Based Scaffolds as Anticancer Agents’, Polycyclic Aromatic Compounds, DOI: 10.1080/10406638.2021.1886123. (Kapoor, G., Bhutani, R., Pathak, D.P., Chauhan, G., Kant, R., Grover, P., Nagarajan K., Siddiqui, S.A., 2021)
Rubina’s research interests are focused on medicinal chemistry, Drug Discovery and Development, Synthetic and Organic Chemistry, Docking Studies.
Contribution to the Profession and Awards (from 2015)
Reviewer in Bioorganic Chemistry journal.
Reviewer in Studies in Natural Product Chemistry journal.
Reviewer in Future Medicinal Chemistry journal.
Rubina’s current research interests are focused on anti-diabetic agents & anti-inflammatory agents.
Placement Expert Talk to Expert